Manufacture

How can pharma help save the environment? We need to use green chemistry, reduce cleanroom sizes, and use less energy.

Matthew Zustiak from Thermo Fisher Scientific discusses the challenges of equipment choice for producing mAbs.

We dig into the story of Lonza in China, and its new HPAPI expansion in Guangzhou

Efficient and reliable scale up is a key component of mAb production.

Efficient, reliable scale up is a key component of mAb production. Thermo Fisher Scientific’s modularized system provides individual building blocks.

Viral vectors can enable innovative medical treatments, but only with a comprehensive formulation development plan

From improving solubility and bioavailability to making formulations suitable for inhalation – micronization is a versatile technique.

Viral vector manufacture has come a long way, but the story is far from over.

Cytiva is transforming in the wake of COVID-19 – but what lessons can the wider biopharma industry take forward?

PCI has focused on becoming a trusted CDMO partner by building strong working relationships with clients.